vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $140.7M, roughly 1.5× Purple Innovation, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -2.3%, a 10.5% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 9.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-7.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 8.3%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
COLL vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $140.7M |
| Net Profit | $17.0M | $-3.2M |
| Gross Margin | 62.5% | 41.9% |
| Operating Margin | 29.6% | -1.6% |
| Net Margin | 8.3% | -2.3% |
| Revenue YoY | 12.9% | 9.1% |
| Net Profit YoY | 35.3% | 62.1% |
| EPS (diluted) | $0.48 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $140.7M | ||
| Q3 25 | $209.4M | $118.8M | ||
| Q2 25 | $188.0M | $105.1M | ||
| Q1 25 | $177.8M | $104.2M | ||
| Q4 24 | $181.9M | $129.0M | ||
| Q3 24 | $159.3M | $118.6M | ||
| Q2 24 | $145.3M | $120.3M | ||
| Q1 24 | $144.9M | $120.0M |
| Q4 25 | $17.0M | $-3.2M | ||
| Q3 25 | $31.5M | $-11.7M | ||
| Q2 25 | $12.0M | $-17.3M | ||
| Q1 25 | $2.4M | $-19.1M | ||
| Q4 24 | $12.5M | $-8.5M | ||
| Q3 24 | $9.3M | $-39.2M | ||
| Q2 24 | $19.6M | $27.0K | ||
| Q1 24 | $27.7M | $-50.2M |
| Q4 25 | 62.5% | 41.9% | ||
| Q3 25 | 61.7% | 42.8% | ||
| Q2 25 | 57.7% | 35.9% | ||
| Q1 25 | 54.8% | 39.4% | ||
| Q4 24 | 54.0% | 42.9% | ||
| Q3 24 | 60.8% | 29.7% | ||
| Q2 24 | 62.5% | 40.7% | ||
| Q1 24 | 63.1% | 34.8% |
| Q4 25 | 29.6% | -1.6% | ||
| Q3 25 | 29.7% | -10.2% | ||
| Q2 25 | 18.7% | -13.5% | ||
| Q1 25 | 12.2% | -13.9% | ||
| Q4 24 | 20.9% | -6.0% | ||
| Q3 24 | 21.9% | -39.5% | ||
| Q2 24 | 32.7% | -12.1% | ||
| Q1 24 | 34.1% | -19.3% |
| Q4 25 | 8.3% | -2.3% | ||
| Q3 25 | 15.0% | -9.9% | ||
| Q2 25 | 6.4% | -16.5% | ||
| Q1 25 | 1.4% | -18.4% | ||
| Q4 24 | 6.9% | -6.6% | ||
| Q3 24 | 5.9% | -33.1% | ||
| Q2 24 | 13.5% | 0.0% | ||
| Q1 24 | 19.1% | -41.8% |
| Q4 25 | $0.48 | $0.03 | ||
| Q3 25 | $0.84 | $0.11 | ||
| Q2 25 | $0.34 | $0.16 | ||
| Q1 25 | $0.07 | $0.18 | ||
| Q4 24 | $0.36 | $0.08 | ||
| Q3 24 | $0.27 | $0.36 | ||
| Q2 24 | $0.52 | $0.00 | ||
| Q1 24 | $0.71 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $301.7M | $-29.7M |
| Total Assets | $1.7B | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $24.3M | ||
| Q3 25 | $285.9M | $32.4M | ||
| Q2 25 | $222.2M | $34.2M | ||
| Q1 25 | $197.8M | $21.6M | ||
| Q4 24 | $162.8M | $29.0M | ||
| Q3 24 | $120.0M | $23.4M | ||
| Q2 24 | $271.6M | $23.4M | ||
| Q1 24 | $318.0M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $301.7M | $-29.7M | ||
| Q3 25 | $274.8M | $-26.9M | ||
| Q2 25 | $232.2M | $-15.6M | ||
| Q1 25 | $234.4M | $1.3M | ||
| Q4 24 | $228.8M | $20.2M | ||
| Q3 24 | $234.3M | $28.0M | ||
| Q2 24 | $216.6M | $66.4M | ||
| Q1 24 | $222.2M | $65.5M |
| Q4 25 | $1.7B | $296.3M | ||
| Q3 25 | $1.6B | $302.1M | ||
| Q2 25 | $1.6B | $303.8M | ||
| Q1 25 | $1.6B | $293.8M | ||
| Q4 24 | $1.7B | $307.8M | ||
| Q3 24 | $1.6B | $309.3M | ||
| Q2 24 | $1.1B | $362.1M | ||
| Q1 24 | $1.1B | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-5.8M |
| Free Cash FlowOCF − Capex | $122.4M | $-7.8M |
| FCF MarginFCF / Revenue | 59.6% | -5.5% |
| Capex IntensityCapex / Revenue | 0.3% | 1.4% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-5.8M | ||
| Q3 25 | $78.4M | $-968.0K | ||
| Q2 25 | $72.4M | $-4.0M | ||
| Q1 25 | $55.4M | $-23.1M | ||
| Q4 24 | $84.6M | $6.8M | ||
| Q3 24 | $-9.0M | $1.1M | ||
| Q2 24 | $67.4M | $-8.9M | ||
| Q1 24 | $61.9M | $-16.8M |
| Q4 25 | $122.4M | $-7.8M | ||
| Q3 25 | $78.3M | $-1.8M | ||
| Q2 25 | $72.4M | $-7.0M | ||
| Q1 25 | $54.6M | $-25.3M | ||
| Q4 24 | $84.1M | $5.7M | ||
| Q3 24 | $-9.2M | $101.0K | ||
| Q2 24 | $67.1M | $-11.0M | ||
| Q1 24 | $61.4M | $-19.9M |
| Q4 25 | 59.6% | -5.5% | ||
| Q3 25 | 37.4% | -1.5% | ||
| Q2 25 | 38.5% | -6.6% | ||
| Q1 25 | 30.7% | -24.3% | ||
| Q4 24 | 46.2% | 4.4% | ||
| Q3 24 | -5.8% | 0.1% | ||
| Q2 24 | 46.2% | -9.2% | ||
| Q1 24 | 42.3% | -16.5% |
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.4% | 2.2% | ||
| Q4 24 | 0.3% | 0.8% | ||
| Q3 24 | 0.2% | 0.9% | ||
| Q2 24 | 0.2% | 1.7% | ||
| Q1 24 | 0.4% | 2.5% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | -330.22× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
